These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Mydeton: a centrally acting muscle relaxant drug from Gedeon Richter LTD]. Kocsis P; Tarnawa I; Kovács G; Szombathelyi Z; Farkas S Acta Pharm Hung; 2002; 72(1):49-61. PubMed ID: 12426787 [TBL] [Abstract][Full Text] [Related]
5. Successful use of mydocalm in peripheral arterial disease. MOLNAR L Ther Hung; 1962; 10():10-2. PubMed ID: 13935926 [No Abstract] [Full Text] [Related]
6. [MYDOCALM TREATMENT OF PSEUDO-PARKINSON DISORDERS FOLLOWING THE ADMINISTRATION OF NEUROLEPTIC AGENTS]. BLONDEL F; COULEON M; COULEON H; ANNE L; CLERC G; COULOMBIER J; TRENQUALYEJP DE Ann Med Psychol (Paris); 1964 Dec; 122():755-8. PubMed ID: 14252013 [No Abstract] [Full Text] [Related]
7. Stereochemical study of tolperisone, a muscle relaxant agent, by circular dichroism and ultraviolet spectroscopy. Zsila F; Hollósi M; Gergely A Chirality; 2000 Nov; 12(10):720-6. PubMed ID: 11054830 [TBL] [Abstract][Full Text] [Related]
8. [The effect of Mydeton on the psychic activity in cases of mental retardation]. Schwabik J; Péterfai J Orv Hetil; 1967 Jan; 108(4):157-60. PubMed ID: 6047454 [No Abstract] [Full Text] [Related]
9. [Mydocalm, a new drug to relax spastic muscles in neurological diseases]. LEHOCZKY T Ther Hung; 1961; 9():10-3. PubMed ID: 13929385 [No Abstract] [Full Text] [Related]
10. [EXPERIENCE WITH A MYOTONOLYTIC (MYDOCALM) IN THE TREATMENT OF ARTERIAL OCCLUSIVE DISEASE OF THE EXTREMITIES]. LINKE H Wien Med Wochenschr; 1964 May; 114():314-20. PubMed ID: 14232726 [No Abstract] [Full Text] [Related]
11. Determination of tolperisone in pharmaceutical formulations by g. l. c. Gazdag M; Szepesi G; Nyiredy S Pharmazie; 1978 Aug; 33(8):538-9. PubMed ID: 724787 [No Abstract] [Full Text] [Related]
12. [Combined use of pharmacological preparations and a method of functional biocontrol in children with spastic forms of infantile cerebral palsy]. Shaĭtor VM; Bogdanov OV Pediatriia; 1988; (2):111-2. PubMed ID: 3375017 [No Abstract] [Full Text] [Related]
13. [PERIPHERAL VASODILATOR ACTION OF MYDETON]. SOOS S Orv Hetil; 1964 Jul; 105():1369-72. PubMed ID: 14181919 [No Abstract] [Full Text] [Related]
14. [Effects of tolperisone hydrochloride on the silent period of the masseter muscle]. Kawamura S; Iwasaki T; Okamura T; Nishikawa T; Nakajima H; Fujiwara H; Funakoshi M Gifu Shika Gakkai Zasshi; 1986 Dec; 13(2):311-21. PubMed ID: 3505251 [No Abstract] [Full Text] [Related]
15. Several years of observation with Mydeton in the treatment of lockjaw. Inovay J; Katona J Ther Hung; 1991; 39(4):185-7. PubMed ID: 1811331 [TBL] [Abstract][Full Text] [Related]
16. [Effect of tolperisone-HCl on the chewing patterns in rats]. Kawamrua S; Katsukawa H; Noda K; Nishikawa T; Okamura T Gifu Shika Gakkai Zasshi; 1985 Jun; 12(2):239-44. PubMed ID: 3866786 [No Abstract] [Full Text] [Related]
17. [Inhibitory effect of tolperisone-HCI (Muscalm) on the reflex activity of the rat masticatory muscles]. Mori A Shikai Tenbo; 1985 May; 65(5):1133-41. PubMed ID: 3865397 [No Abstract] [Full Text] [Related]
18. Clinical examination of the synergistic effect of niflumic acid and tolperisone in genicular arthritis. Dömötör E Ther Hung; 1979; 27(3):129-33. PubMed ID: 531773 [No Abstract] [Full Text] [Related]